[1]
A. I. Severina, D. P. Kavraiskyi, I. V. Kovalevska, S. Y. Shtrygol’, E. A. Ruban, and V. A. Georgiyants, “Dependence of anticonvulsant activity of 1-aryl-1, 5-dihydro-4H-pyrazole (3,4-d) pyrimidine-4-one derivatives on biopharmaceutical factors”, Int J Basic Clin Pharmacol, vol. 6, no. 7, pp. 1552–1559, Jun. 2017.